Less than two months after leaving his post as FDA commissioner, Scott Gottlieb, MD, has been appointed as a special partner on New Enterprise Associates' healthcare investment team.
Dr. Gottlieb was a venture partner at NEA from 2007 to 2017 before being appointed commissioner of the FDA. He's rejoining the venture capital firm after stepping down from his position at the FDA in April.
Dr. Gottlieb, who was the 23rd commissioner of the FDA, is an elected member of the National Academy of Medicine and a resident fellow at the American Enterprise Institute in Washington, D.C.
More articles on leadership and management:
New Mexico hospital board isn't holding CEO accountable, city commissioner says
AHA creates playbook for addressing burnout
CEOs under 50 are a rare find at America's largest companies